Portfolio company
Dynavax Technologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biopharmaceutical company develops and commercialises novel vaccines and adjuvants for healthcare providers to protect adults against infectious diseases like hepatitis B.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Affinivax
This biopharmaceutical company develops vaccines against infectious diseases and hospital-associated infections for healthcare providers and public health organisations worldwide.
Vaccitech Ltd
This biopharmaceutical company develops immunotherapeutic products and vaccines for patients with chronic infectious diseases, autoimmune conditions and cancer.
Eubiologics
This biopharmaceutical company manufactures vaccines for global health organisations and provides contract research and manufacturing services to the biotechnology industry.
Hookipa Pharma
This biopharmaceutical company develops arenavirus-based immunotherapies to treat infectious diseases and cancers for patients and healthcare providers.
GlycoVaxyn
This biotechnology company develops bioconjugate vaccines for pharmaceutical partners to prevent and treat bacterial infections.
Vaxdyn
Vaxdyn develops multivalent vaccines to prevent antibiotic-resistant bacterial infections for high-risk populations, including hospital patients and those with chronic diseases.
Antios Therapeutics
This clinical-stage biopharmaceutical company develops antiviral therapies to treat and cure patients with chronic hepatitis B virus infections.
Pharmexa A/S
This company develops active immunotherapy and peptide vaccines for patients with cancer, chronic illnesses, and infectious diseases.
